mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.06 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.06 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.56 |
0.06 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |